Your browser doesn't support javascript.
loading
Synergistic effect of FOXM1 and BCL-2 inhibition in a preclinical treatment study on multiple myeloma.
Zhou, Vivian; Yu, Manya; Fu, Jiaqi; Janz, Siegfried; Cui, Xing.
Affiliation
  • Zhou V; Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
  • Yu M; Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
  • Fu J; The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, PRC, China.
  • Janz S; The First School of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, 250001, Shandong Province, PRC, China.
  • Cui X; Department of Medicine, Cancer Center-Froedtert Hospital, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. sjanz@mcw.edu.
J Transl Med ; 22(1): 638, 2024 Jul 08.
Article in En | MEDLINE | ID: mdl-38977990
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins c-bcl-2 / Drug Synergism / Forkhead Box Protein M1 / Multiple Myeloma Limits: Humans Language: En Journal: J Transl Med Year: 2024 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins c-bcl-2 / Drug Synergism / Forkhead Box Protein M1 / Multiple Myeloma Limits: Humans Language: En Journal: J Transl Med Year: 2024 Type: Article Affiliation country: United States